Johnson & Johnson Says Darzalex Faspro Showed Increased MRD-Negative Rates in Multiple Myeloma Study-February 2024-www.financetom.com

Johnson & Johnson Says Darzalex Faspro Showed Increased MRD-Negative Rates in Multiple Myeloma Study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Johnson & Johnson Says Darzalex Faspro Showed Increased MRD-Negative Rates in Multiple Myeloma Study

Sep 28, 2024 1:52 AM

02:12 PM EDT, 09/27/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday that its phase 3 Auriga study showed Darzalex Faspro plus lenalidomide significantly improved MRD-negative conversion rates at 12 months compared to lenalidomide alone in patients with newly-diagnosed multiple myeloma.

The combination also indicated a potential benefit in progression-free survival with no new safety concerns, Johnson & Johnson ( JNJ ) said.

Johnson & Johnson ( JNJ ) shares were up 0.6% in recent Friday trading.

Price: 162.33, Change: +0.94, Percent Change: +0.58

Previous page： Gartner Insider Sold Shares Worth $363,656, According to a Recent SEC Filing Next page： Hershey Insider Sold Shares Worth $306,810, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Gartner Insider Sold Shares Worth $363,656, According to a Recent SEC Filing

May 24, 2024

04:16 PM EDT, 05/24/2024 (MT Newswires) -- Alwyn Dawkins, Executive Vice President, Global Business Sales, on May 22, 2024, sold 800 shares in Gartner ( IT ) for $363,656. Following the Form 4 filing with the SEC, Dawkins has control over a total of 50,783 shares of the company, with 50,783 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/749251/000112760224016561/xslF345X03/form4.xml Price: 439.04, Change:...

Hershey Insider Sold Shares Worth $306,810, According to a Recent SEC Filing

May 24, 2024

04:12 PM EDT, 05/24/2024 (MT Newswires) -- Steven E Voskuil, Senior Vice President, Chief Financial Officer, on May 23, 2024, sold 1,500 shares in Hershey (HSY) for $306,810. Following the Form 4 filing with the SEC, Voskuil has control over a total of 37,228 shares of the company, with 37,228 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/47111/000112760224016555/xslF345X03/form4.xml Price: 197.50, Change: +0.50,...

Integra Lifesciences Holdings Insider Bought Shares Worth $1,499,979, According to a Recent SEC Filing

May 24, 2024

04:12 PM EDT, 05/24/2024 (MT Newswires) -- Stuart Essig, Director, Executive Chairman of the Board, on May 23, 2024, executed a purchase for 52,641 shares in Integra Lifesciences Holdings ( IART ) for $1,499,979. Following the Form 4 filing with the SEC, Essig has control over a total of 1,753,434 shares of the company, with 487,922 shares held directly and...

Paycom Software Insider Sold Shares Worth $690,102, According to a Recent SEC Filing

May 24, 2024

04:14 PM EDT, 05/24/2024 (MT Newswires) -- Chad R. Richison, 10% Owner, Director, Co-CEO, President and Chairman, on May 23, 2024, sold 3,900 shares in Paycom Software ( PAYC ) for $690,102. Following the Form 4 filing with the SEC, Richison has control over a total of 6,764,541 shares of the company, with 3,084,158 shares held directly and 3,680,383 controlled...